Document Detail


Imaging of tumor vascularization using fluorescence molecular tomography to monitor arginine deiminase treatment in melanoma.
MedLine Citation:
PMID:  23348793     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
AbstractBased on their inability to express argininosuccinate synthetase (ASS), some cancer entities feature the characteristic of l-arginine (Arg) auxotrophy. This inability to intrinsically generate Arg makes them applicable for arginine deiminase (ADI) treatment, an Arg-depleting drug. Arg is also used for the synthesis of endothelial nitric oxide (NO), which mainly confers vasodilatation but is also considered to have a major influence on tumor vascularization. The purpose of this study was to define changes in tumor vasculature in an ADI-treated melanoma xenograft mouse model using the blood pool agent AngioSense 750 and fluorescence molecular tomography (FMT). We used an ASS-negative melanoma xenograft mouse model and subjected it to weekly ADI treatment. Changes in tumor size were measured, and alterations in tumor vasculature were depicted by FMT and CD31 immunohistochemistry (IHC). On ADI treatment and effective antitumor therapy, we observed a drop in NO plasma levels and visualized changes in tumor vascularization with FMT and IHC. ADI treatment in melanoma xenografts has a tumor-reducing effect, which can be noninvasively imaged by quantifying tumor vascularization with FMT and IHC.
Authors:
Lars Stelter; Michael J Evans; Achim A Jungbluth; Valerie A Longo; Pat Zanzonico; Gerd Ritter; John S Bomalaski; Lloyd Old; Steven M Larson
Related Documents :
15375543 - Sialylated core 1 based o-linked glycans enhance the growth rate of mammary carcinoma c...
25017943 - Blocking lipid synthesis overcomes tumor regrowth and metastasis after antiangiogenic t...
20382143 - The yin and yang functions of the myc oncoprotein in cancer development and as targets ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Molecular imaging     Volume:  12     ISSN:  1536-0121     ISO Abbreviation:  Mol Imaging     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-01-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101120118     Medline TA:  Mol Imaging     Country:  United States    
Other Details:
Languages:  eng     Pagination:  67-73     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Quantitative Magnetic Resonance Imaging in the Transgenic APC?468 Mouse Model of Hereditary Colon Ca...
Next Document:  Thermodynamic stability and relaxation studies of small, triaza-macrocyclic Mn(ii) chelates.